2010 | Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function | CLINICAL AND EXPERIMENTAL HYPERTENSION |
2021 | Left ventricular outflow obstruction occurs immediately after exercise in patients with non-obstructive hypertrophic cardiomyopathy | REVIEWS IN CARDIOVASCULAR MEDICINE |
2008 | Left ventricular remodeling can be predicted with left ventricular volume response during dobutamine echocardiography after acute myocardial infarction | CLINICAL CARDIOLOGY |
2020 | Left ventricular response after cardiac resynchronization therapy is related to early left atrial volume reduction
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2003 | Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-α or -γ agonists in a type 2 diabetic animal model | DIABETES-METABOLISM RESEARCH AND REVIEWS |
2015 | Leiomyosarcoma: investigation of prognostic factors for risk-stratification model | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY |
2021 | Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity
| BLOOD RESEARCH |
2013 | Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells
| ONCOLOGY LETTERS |
2014 | Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients | ANNALS OF HEMATOLOGY |
2023 | Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study | THYROID |
2020 | Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea | THYROID |
2021 | Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale
| FUTURE ONCOLOGY |
2021 | Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma | NEW ENGLAND JOURNAL OF MEDICINE |
2023 | Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study | LANCET ONCOLOGY |
2013 | Leptin/Adiponectin Ratio Is an Independent Predictor of Mortality in Nondiabetic Peritoneal Dialysis Patients
| PERITONEAL DIALYSIS INTERNATIONAL |
2001 | Leptomeningeal Carcinomatosis in Solid Tumors ; Clinical Manifestation and Treatment
| Journal of the Korean Cancer Association (대한암학회지) |
2020 | Lesion-Based Convolutional Neural Network in Diagnosis of Early Gastric Cancer
| CLINICAL ENDOSCOPY |
2019 | Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study | THYROID |
2020 | Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study | EUROPEAN HEART JOURNAL |